相关实验视频
Updated: Jun 4, 2025
11:28
Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
18.0K
氧化建模及其由红细胞影响的生物利用性
Ananta Kumar Nayak1, Marco Canepari1, Sovan Lal Das2
1Université Grenoble Alpes, CNRS, LIPhy, Grenoble 38000, France.
Journal of the Royal Society, Interface
|December 18, 2024
概括
红细胞 (RBC) 度增加会增加ATP和Ca2+,但会降低氧化 (NO) 水平,影响NO的生物可用性,特别是在狭窄的血管中.
科学领域:
- 计算流体动力学的流体动力学.
- 生物医学工程 生物医学工程
- 生理学 生理学 生理学
背景情况:
- 氧化 (NO) 对于维持血管度至关重要,并且在内皮细胞 (ECs) 中产生.
- 的产生受到细胞质Ca2+和剪切应激的调节,受红细胞 (红细胞) 的腺三酸盐 (ATP) 的影响.
- 红细胞也可以清理NO,影响其生物可用性.
研究的目的:
- 为了建模ATP和切割压力依赖的NO生产,整合生化途径.
- 研究RBC度,流量和容器几何学对NO生物可用性的影响.
- 了解血液循环中的NO动态的空间变化.
主要方法:
- 开发一个结合ATP和切削应力依赖NO生产的计算模型.
- 利用沉浸边界格子博尔茨曼方法来模拟RBC流动,ATP释放和NO动态.
- 在一个具有不同血管宽度和红细胞度的二维通道中进行分析.
主要成果:
- 升高的红细胞度增加了ATP和细胞质Ca2+,但在所有通道宽度上降低了NO度.
- NO的生物可用性受到红细胞分布的显著影响,特别是在狭窄的道中.
- 观察到两种不同的NO生物可用性阶段:低RBC度显著变化和高RBC度最小变化.
结论:
- 红细胞度和分布是NO生物可用性的关键决定因素.
- 船舶的限制和流量条件调节NO动态.
- 研究结果提供了对微血管网络中NO依赖的血管扩张和氧气运输的见解.
相关概念视频
01:28Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
01:23Antihypertensive Drugs: Vasodilators
474
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
474
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
62
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
62
01:16Antianginal Drugs: Nitrates and β-Blockers
517
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517
01:13Bioavailability: Overview
2.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.7K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K